Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inhibrx Biosciences, Inc. - Common Stock (NQ:INBX)

79.17 -2.49 (-3.05%)
Streaming Delayed Price Updated: 9:39 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,055
Open 80.25
Bid (Size) 78.75 (100)
Ask (Size) 79.58 (100)
Prev. Close 81.66
Today's Range 77.58 - 80.53
52wk Range 10.80 - 83.95
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Thursday's session
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Unusual volume stocks are being observed in Tuesday's session. 
Via Chartmill

Performance

YTD
+419.1%
+419.1%
1 Month
+122.1%
+122.1%
3 Month
+263.2%
+263.2%
6 Month
+542.1%
+542.1%
1 Year
+409.1%
+409.1%

More News

Read More
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Economy
Inhibrx Biosciences Soars Over 90% on Breakthrough Rare Bone Cancer Trial Results
Via MarketMinute
Why Is INBX Stock Rising Today?
Via Stocktwits
INBX Stock Earnings: Inhibrx Beats EPS for Q1 2024
Via InvestorPlace
Here are the top movers in Friday's session.
Via Chartmill
Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday?
Via Benzinga
Topics Economy
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
What's going on in today's session
Via Chartmill
Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October
Via Benzinga
Topics Stocks
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
Via MarketMinute
Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday
Via Benzinga
Which stocks are gapping on Friday?
Via Chartmill
Get insights into the top gainers and losers of Friday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Are Inhibrx Biosciences Shares Soaring 76% After Hours?
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Inhibrx Biosciences Beats Earnings
Via The Motley Fool
Topics Intellectual Property
Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying
Via Benzinga
Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying
Via Benzinga
INBX Stock Earnings: Inhibrx Biosciences Beats EPS for Q2 2024
Via InvestorPlace

Frequently Asked Questions

Is Inhibrx Biosciences, Inc. - Common Stock publicly traded?
Yes, Inhibrx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Inhibrx Biosciences, Inc. - Common Stock trade on?
Inhibrx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibrx Biosciences, Inc. - Common Stock?
The ticker symbol for Inhibrx Biosciences, Inc. - Common Stock is INBX on the Nasdaq Stock Market
What is the current price of Inhibrx Biosciences, Inc. - Common Stock?
The current price of Inhibrx Biosciences, Inc. - Common Stock is 79.17
When was Inhibrx Biosciences, Inc. - Common Stock last traded?
The last trade of Inhibrx Biosciences, Inc. - Common Stock was at 11/03/25 09:39 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.